siltuximab
teratocarcinoma
taplitumomab
teprotumumab
seminoma
malignin
tabalumab
mapatumumab
catumaxomab
amivantamab
alacizumab
oportuzumab monatox
ertumaxomab
dalotuzumab
-mel-
pseudocapsule
testiculomata
tisotumab
oncotropic
sibrotuzumab
tumorous
caplacizumab
citatuzumab bogatox
iratumumab
edrecolomab
pintumomab
oncoimmunology
-gov-
cergutuzumab
immunoenzymatic
zalutumumab
-mab
immunochemiluminometric
monoantibody
agonistic monoclonal antibody
neoplastic cell
apolizumab
-mar-
durvalumab
pritumumab
ensituximab
antimonoclonal
histiocytoma
microlymphocytotoxicity
nimotuzumab
nacolomab tafenatox
malignancy
onco-
oncocytoma
colosphere